Efficacy and survival analysis of apatinib combined with capecitabine chemotherapy for second-line treatment of advanced esophageal cancer. IJCT [Internet]. 2023 May 31 [cited 2026 May 15];29(6):793-8. Available from: https://or.niscpr.res.in/index.php/IJCT/article/view/2161